DBV Technologies (DBVT) Cash & Equivalents (2015 - 2026)

DBV Technologies (DBVT) reported Cash & Equivalents of $229.2 million for Q1 2026, up 1668.25% year-over-year from $13.0 million in Q1 2025, and up 18.02% quarter-over-quarter from $194.2 million in Q4 2025.

DBV Technologies (DBVT) Cash & Equivalents (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Cash & Equivalents data on file, last reported at $229.2 million in Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $229.2 million, up 1668.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $229.2 million (up 1668.25% YoY), and the FY2025 annual result was $194.2 million, up 498.35% from the prior year.
  • Cash & Equivalents grew to $229.2 million in Q1 2026 per DBVT's latest filing, from $194.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $248.0 million in Q2 2022 and troughed at $13.0 million in Q1 2025.
  • A 5-year average of $132.7 million and a median of $141.4 million in 2023 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2025 and 2026: Cash & Equivalents sank 87.23% in 2025, then soared 1668.25% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $209.2 million in 2022, then tumbled by 32.42% to $141.4 million in 2023, then plunged by 77.04% to $32.5 million in 2024, then jumped by 498.35% to $194.2 million in 2025, then climbed by 18.02% to $229.2 million in 2026.
  • Business Quant data shows DBVT's Cash & Equivalents at $229.2 million in Q1 2026, $194.2 million in Q4 2025, and $69.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 229.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 229.20 Mn
Dec 31, 2025 194.20 Mn
Sep 30, 2025 69.84 Mn
Jun 30, 2025 103.20 Mn
Mar 31, 2025 12.96 Mn
Dec 31, 2024 32.46 Mn
Sep 30, 2024 46.40 Mn
Jun 30, 2024 66.21 Mn
Mar 31, 2024 101.53 Mn
Dec 31, 2023 141.37 Mn
Sep 30, 2023 149.14 Mn
Jun 30, 2023 173.96 Mn
Mar 31, 2023 192.29 Mn
Dec 31, 2022 209.19 Mn
Sep 30, 2022 212.67 Mn
Jun 30, 2022 247.97 Mn
Mar 31, 2022 74.10 Mn
Dec 31, 2021 77.30 Mn
Sep 30, 2021 98.20 Mn
Jun 30, 2021 125.50 Mn